	US 11,690,822 B2
	Method for treating non-compaction cardiomyopathy
Wen-Pin Chen, Taipei (TW); Mei-Hwan Wu, Taipei (TW); and Hong-Nerng Ho, Taipei (TW)
Assigned to EXCELSIOR PHARMATECH LABS, Taipei (TW); and NATIONAL TAIWAN UNIVERSITY, Taipei (TW)
Appl. No. 15/734,315
Filed by Wen-Pin Chen, Taipei (TW); and EXCELSIOR PHARMATECH LABS, Taipei (TW)
PCT Filed May 23, 2019, PCT No. PCT/CN2019/088156 § 371(c)(1), (2) Date Dec. 2, 2020, PCT Pub. No. WO2019/233285, PCT Pub. Date Dec. 12, 2019.
Claims priority of provisional application 62/679,968, filed on Jun. 3, 2018.
Prior Publication US 2021/0220327 A1, Jul. 22, 2021
Int. Cl. A61K 31/366 (2006.01); A61P 9/04 (2006.01); A61K 9/00 (2006.01)

CPC A61K 31/366 (2013.01) [A61P 9/04 (2018.01); A61K 9/0024 (2013.01)]

11 Claims

1. A method for treating a subject suffering from non-compaction cardiomyopathy, comprising administering to the subject suffering from non-compaction cardiomyopathy a pharmaceutical composition comprising a therapeutically effective amount of a EZH2 downregulator.